Literature DB >> 7560099

A mouse model for the delta F508 allele of cystic fibrosis.

B G Zeiher1, E Eichwald, J Zabner, J J Smith, A P Puga, P B McCray, M R Capecchi, M J Welsh, K R Thomas.   

Abstract

The most common cause of cystic fibrosis is a mutation that deletes phenylalanine 508 in cystic fibrosis transmembrane conductance regulator (CFTR). The delta F508 protein is misprocessed and degraded rather than traveling to the apical membrane. We used a novel strategy to introduce the delta F508 mutation into the mouse CFTR gene. Affected epithelia from homozygous delta F508 mice lacked CFTR in the apical membrane and were Cl-impermeable. These abnormalities are the same as those observed in patients with delta F508 and suggest that these mice have the same cellular defect. 40% of homozygous delta F508 animals survived into adulthood and displayed several abnormalities found in human disease and in CFTR null mice. These animals should provide an excellent model to investigate pathogenesis and to examine therapies directed at correcting the delta F508 defect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560099      PMCID: PMC185844          DOI: 10.1172/JCI118253

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

2.  Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.

Authors:  W K Lemna; G L Feldman; B Kerem; S D Fernbach; E P Zevkovich; W E O'Brien; J R Riordan; F S Collins; L C Tsui; A L Beaudet
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

3.  Hyposecretion of beta-adrenergically induced sweating in cystic fibrosis heterozygotes.

Authors:  J K Behm; G Hagiwara; N J Lewiston; P M Quinton; J J Wine
Journal:  Pediatr Res       Date:  1987-09       Impact factor: 3.756

4.  Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis.

Authors:  H J Veeze; M Sinaasappel; J Bijman; J Bouquet; H R de Jonge
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

5.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

6.  Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development.

Authors:  K R Thomas; M R Capecchi
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

7.  Nasal potential difference: a clinical diagnostic test for cystic fibrosis.

Authors:  E W Alton; D Currie; R Logan-Sinclair; J O Warner; M E Hodson; D M Geddes
Journal:  Eur Respir J       Date:  1990-09       Impact factor: 16.671

8.  Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation.

Authors:  R C Boucher; M J Stutts; M R Knowles; L Cantley; J T Gatzy
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

9.  Altered intestinal chloride transport in cystic fibrosis.

Authors:  H M Berschneider; M R Knowles; R G Azizkhan; R C Boucher; N A Tobey; R C Orlando; D W Powell
Journal:  FASEB J       Date:  1988-07       Impact factor: 5.191

10.  Variable reduction in beta-adrenergic sweat secretion in cystic fibrosis heterozygotes.

Authors:  K Sato; F Sato
Journal:  J Lab Clin Med       Date:  1988-05
View more
  127 in total

Review 1.  Animal models of chronic obstructive pulmonary disease.

Authors:  P A Dawkins; R A Stockley
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles.

Authors:  Long Ye; John M Knapp; Panjamaporn Sangwung; James C Fettinger; A S Verkman; Mark J Kurth
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

3.  Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Authors:  R V Farese; M M Véniant; C M Cham; L M Flynn; V Pierotti; J F Loring; M Traber; S Ruland; R S Stokowski; D Huszar; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Transgenic hCFTR expression fails to correct β-ENaC mouse lung disease.

Authors:  B R Grubb; W K O'Neal; L E Ostrowski; S M Kreda; B Button; R C Boucher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

5.  Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice.

Authors:  Mathilde Beka; Teresinha Leal
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

6.  Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.

Authors:  Mark W Musch; Yunwei Wang; Erika C Claud; Eugene B Chang
Journal:  Dig Dis Sci       Date:  2013-01-18       Impact factor: 3.199

7.  Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype.

Authors:  F J McDonald; B Yang; R F Hrstka; H A Drummond; D E Tarr; P B McCray; J B Stokes; M J Welsh; R A Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Quorum sensing inhibitory effect of bergamot oil and aspidosperma extract against Chromobacterium violaceum and Pseudomonas aeruginosa.

Authors:  Sarah Omar Ahmed; Hamdallah Hafez Zedan; Yasser Musa Ibrahim
Journal:  Arch Microbiol       Date:  2021-06-27       Impact factor: 2.552

Review 9.  Animal models for cystic fibrosis liver disease (CFLD).

Authors:  Romina Fiorotto; Mariangela Amenduni; Valeria Mariotti; Massimiliano Cadamuro; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-07-30       Impact factor: 5.187

10.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.